Promoter methylation of argininosuccinate synthetase-1 sensitises lymphomas to arginine deiminase treatment, autophagy and caspase-dependent apoptosis
暂无分享,去创建一个
J. Gribben | J. Fitzgibbon | L. Maharaj | S. Joel | B. Delage | N. Lemoine | T. Crook | P. Szlosarek | N. Syed | E. Hatzimichael | J. Bomalaski | T. Mitchell | P. Luong | R. Cerio | S. Whittaker | C. Ó'Riain | J. Gribben | Lenushka Maharaj | A. Papoudou-Bai | C-F Li | L.-T. Chen | Tim Crook | Alexandra Papoudou-Bai | Tracey J. Mitchell | Sean Whittaker | Rino Cerio | John G. Gribben | Nicholas R. Lemoine | Simon P. Joel | Jude Fitzgibbon | L-T. Chen | R. Cerio | N. R. Lemoine
[1] Hui-Kuan Lin,et al. Activation of Ras/PI3K/ERK pathway induces c-Myc stabilization to upregulate argininosuccinate synthetase, leading to arginine deiminase resistance in melanoma cells. , 2012, Cancer research.
[2] I. Sheen,et al. A randomised phase II study of pegylated arginine deiminase (ADI-PEG 20) in Asian advanced hepatocellular carcinoma patients , 2010, British Journal of Cancer.
[3] B. Delage,et al. Arginine deprivation and argininosuccinate synthetase expression in the treatment of cancer , 2010, International journal of cancer.
[4] F. Izzo,et al. Phase II study of pegylated arginine deiminase for nonresectable and metastatic hepatocellular carcinoma. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[5] E. Gottlieb,et al. Targeting metabolic transformation for cancer therapy , 2010, Nature Reviews Cancer.
[6] S. Hirohashi,et al. Reduced Argininosuccinate Synthetase Is a Predictive Biomarker for the Development of Pulmonary Metastasis in Patients with Osteosarcoma , 2010, Molecular Cancer Therapeutics.
[7] N. Savaraj,et al. Resistance to arginine deiminase treatment in melanoma cells is associated with induced argininosuccinate synthetase expression involving c-Myc/HIF-1α/Sp4 , 2009, Molecular Cancer Therapeutics.
[8] L. Nicholson,et al. Epigenetic silencing of argininosuccinate synthetase confers resistance to platinum‐induced cell death but collateral sensitivity to arginine auxotrophy in ovarian cancer , 2009, International journal of cancer.
[9] M. Munder,et al. l-Arginine deprivation impairs Leishmania major-specific T-cell responses , 2009, European journal of immunology.
[10] Randy D. Gascoyne,et al. Array-based DNA methylation profiling in follicular lymphoma , 2009, Leukemia.
[11] P. Meltzer,et al. Large-scale profiling of archival lymph nodes reveals pervasive remodeling of the follicular lymphoma methylome. , 2009, Cancer research.
[12] Frank Y. S. Chuang,et al. Arginine deiminase as a novel therapy for prostate cancer induces autophagy and caspase-independent apoptosis. , 2009, Cancer research.
[13] M. Wangpaichitr,et al. Arginine deprivation as a targeted therapy for cancer. , 2008, Current pharmaceutical design.
[14] G. Evan,et al. Autophagy inhibition enhances therapy-induced apoptosis in a Myc-induced model of lymphoma. , 2007, The Journal of clinical investigation.
[15] D. Fennell,et al. In vivo Loss of Expression of Argininosuccinate Synthetase in Malignant Pleural Mesothelioma Is a Biomarker for Susceptibility to Arginine Depletion , 2006, Clinical Cancer Research.
[16] F. Izzo,et al. Pegylated arginine deiminase treatment of patients with metastatic melanoma: results from phase I and II studies. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[17] V. Bronte,et al. Regulation of immune responses by L-arginine metabolism , 2005, Nature Reviews Immunology.
[18] D. Wheatley,et al. Arginine deiminase enhances dexamethasone‐induced cytotoxicity in human T‐lymphoblastic leukemia CCRF‐CEM cells , 2004, International journal of cancer.
[19] Guoyao Wu,et al. Citrulline Can Preserve Proliferation and Prevent the Loss of CD3 ζ Chain Under Conditions of Low Arginine. , 2004, JPEN. Journal of parenteral and enteral nutrition.
[20] J. Brayer,et al. Arginase I Production in the Tumor Microenvironment by Mature Myeloid Cells Inhibits T-Cell Receptor Expression and Antigen-Specific T-Cell Responses , 2004, Cancer Research.
[21] F. Izzo,et al. Pegylated arginine deiminase treatment of patients with unresectable hepatocellular carcinoma: results from phase I/II studies. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[22] A. Burton,et al. The Effects of Arginine Deficiency on Lymphoma Cells , 1974, British Journal of Cancer.
[23] L. Jacoby. Adaptation of cultured human lymphoblasts to growth in citrulline. , 1974, Experimental cell research.
[24] W. Adler,et al. Effect of Arginine Deficiency on Synthesis of DNA and Immunoglobulin Receptor of Burkitt Lymphoma Cells , 1970, Nature.
[25] Guoyao Wu,et al. Citrulline can preserve proliferation and prevent the loss of CD3 zeta chain under conditions of low arginine. , 2004, JPEN. Journal of parenteral and enteral nutrition.
[26] A. Meijer,et al. The phosphatidylinositol 3-kinase inhibitors wortmannin and LY294002 inhibit autophagy in isolated rat hepatocytes. , 1997, European journal of biochemistry.
[27] K. Sugimura,et al. Elevated gene expression of argininosuccinate synthetase in peripheral lymphocytes from systemic lupus erythematosus (SLE) patients. , 1992, Autoimmunity.